Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis. - Wikidata - awgldk - TriplyDB

Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis.

Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis.

http://www.wikidata.org/entity/Q37547689

about

Osteopontin (OPN) as a CSF and blood biomarker for multiple sclerosis: A systematic review and meta-analysis.Metabolic Dysfunction and Peroxisome Proliferator-Activated Receptors (PPAR) in Multiple Sclerosis.

P2860

Q48217814-5D873D7D-A93D-4EAE-92A2-42865FD1B11F Q55561652-79A5E615-EF5E-418D-A3A3-1B6D1CEC9BDB

P2860

Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis.

http://www.wikidata.org/entity/Q37547689

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Natalizumab Treatment Modulate ...... Women with Multiple Sclerosis.

@en

Natalizumab Treatment Modulate ...... Women with Multiple Sclerosis.

@nl

type

label

Natalizumab Treatment Modulate ...... Women with Multiple Sclerosis.

@en

Natalizumab Treatment Modulate ...... Women with Multiple Sclerosis.

@nl

prefLabel

Natalizumab Treatment Modulate ...... Women with Multiple Sclerosis.

@en

Natalizumab Treatment Modulate ...... Women with Multiple Sclerosis.

@nl

P1433

Q37547689-BF62FE06-F56D-41F3-97F6-0C6C240B292F

P1476

Q37547689-B298508C-7329-4C5C-A9D6-B53DE9D45880

P2093

Q37547689-06689D53-4BFB-4BB9-914E-2CD97103DE82

Q37547689-412AD14D-4890-47CC-A6F2-980ABE6DFA49

Q37547689-BCC7763C-0DD9-4EA3-998B-A47761EF6338

Q37547689-BF791272-9D81-4358-9250-B3AACC2724CB

Q37547689-FD954BB0-BD7B-4DAC-9632-C17B2E826118

P2860

Q37547689-1D5928AF-94DD-429B-9792-DAAC2B6777B1

Q37547689-22A24201-D701-415F-994C-0AB6ED134E19

Q37547689-45D9B878-6B31-4862-8C00-60B310801C7C

Q37547689-4A447FDE-D60A-4BF4-83A5-1AE076535203

Q37547689-4E04B27D-274C-4485-916E-424C92DA30C4

Q37547689-674B6FEB-0AEB-4CA5-B3CB-8845B9A13850

Q37547689-758F5A2B-7506-4979-A1A6-5C09259AE9B4

Q37547689-88ABB719-F16F-437D-8B21-44456317DFB3

Q37547689-89EC761C-DE58-42DB-9FC0-230B7A952545

Q37547689-93BC2322-5D51-4FC2-BADE-D28D31784BC8

P304

Q37547689-1FF83167-72CA-4A9E-97AD-E8C9F74DB7E0

P31

Q37547689-FBBDF66B-0083-40CD-9FC2-C80238653372

P356

Q37547689-F328C35D-2934-4DF8-9B5B-50D5797923D2

P478

Q37547689-B5A798AD-AD52-49AA-9162-D9740710A056

P50

Q37547689-2917B4EA-A866-4AE3-A91F-DD73514F7FA4

Q37547689-99CE89CA-0AE5-4107-A133-EC88F58D019A

Q37547689-DBAD6B22-7D02-439D-ACC2-8ACBD3044C38

Q37547689-E087692E-0672-45D7-9F35-F4EC17335328

P577

Q37547689-5AA4D07E-786B-432E-931C-4DBB6B0D714A

P698

Q37547689-AD2D57FD-DE4E-4AF2-82E3-DC8182CA96FA

P921

Q37547689-5865AE40-34E2-4BE0-AF92-DE51CC2AD489

P932

Q37547689-1DCFEF8E-60AC-4081-8401-8B025D38E6F6

P356

P1433

P1476

Natalizumab Treatment Modulate ...... Women with Multiple Sclerosis

@en

P2093

Alexandra Maia E Silva

http://www.w3.org/2001/XMLSchema#string

Bruno Derudas

http://www.w3.org/2001/XMLSchema#string

Inês Cavaleiro

http://www.w3.org/2001/XMLSchema#string

José Vale

http://www.w3.org/2001/XMLSchema#string

Véronique Ferret-Sena

http://www.w3.org/2001/XMLSchema#string

P2860

Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity

Peroxisome proliferator-activated receptor (PPAR)alpha expression in T cells mediates gender differences in development of T cell-mediated autoimmunity.

Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.

Disrupted balance of T cells under natalizumab treatment in multiple sclerosis.

OSTEOPONTIN: A KEY LINK BETWEEN IMMUNITY, INFLAMMATION AND THE CENTRAL NERVOUS SYSTEM.

PPARalpha and PPARgamma effectively protect against HIV-induced inflammatory responses in brain endothelial cells

Regulation of macrophage functions by PPAR-alpha, PPAR-gamma, and LXRs in mice and men.

Natalizumab treatment is associated with peripheral sequestration of proinflammatory T cells.

The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state.

PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes.

P304

5716415

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2016/5716415

http://www.w3.org/2001/XMLSchema#string

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Giulia Chinetti

P577

2016-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28077943

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

5203914

http://www.w3.org/2001/XMLSchema#string